{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:51:03Z","timestamp":1740178263200,"version":"3.37.3"},"reference-count":39,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>von Willebrand factor (VWF) is an extremely cysteine-rich multimeric protein that is essential for maintaining normal hemostasis. The cysteine residues of VWF monomers form intra- and intermolecular disulfide bonds that regulate its structural conformation, multimer distribution, and ultimately its hemostatic activity. In this study, we investigated and characterized the molecular and pathogenic mechanisms through which a novel cysteine variant p.(Cys1084Tyr) causes an unusual, mixed phenotype form of von Willebrand disease (VWD). Phenotypic data including bleeding scores, laboratory values, VWF multimer distribution, and desmopressin response kinetics were investigated in 5 members (2 parents and 3 daughters) of a consanguineous family. VWF synthesis and secretion were also assessed in a heterologous expression system and in a transient transgenic mouse model. Heterozygosity for p.(Cys1084Tyr) was associated with variable expressivity of qualitative VWF defects. Heterozygous individuals had reduced VWF:GPIbM (&amp;lt;0.40 IU\/mL) and VWF:CB (&amp;lt;0.35 IU\/mL), as well as relative reductions in high-molecular-weight multimers, consistent with type 2A VWD. In addition to these qualitative defects, homozygous individuals also displayed reduced factor VIII (FVIII):C\/VWF:Ag, leading to very low FVIII levels (0.03-0.1 IU\/mL) and reduced VWF:Ag (&amp;lt;0.40 IU\/mL) and VWF:GPIbM (&amp;lt;0.30 IU\/mL). Accelerated VWF clearance and impaired VWF secretion contributed to the fully expressed homozygous phenotype with impaired secretion arising because of disordered disulfide connectivity.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005928","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T20:19:03Z","timestamp":1642018743000},"page":"2908-2919","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Novel cysteine substitution p.(Cys1084Tyr) causes variable expressivity of qualitative and quantitative VWF defects"],"prefix":"10.1182","volume":"6","author":[{"given":"Orla","family":"Rawley","sequence":"first","affiliation":[{"name":"Molecular Hemostasis Research Group, Department of Pathology and Molecular Medicine, Queen\u2019s University, Kingston, ON, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura L.","family":"Swystun","sequence":"additional","affiliation":[{"name":"Molecular Hemostasis Research Group, Department of Pathology and Molecular Medicine, Queen\u2019s University, Kingston, ON, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Brown","sequence":"additional","affiliation":[{"name":"Molecular Hemostasis Research Group, Department of Pathology and Molecular Medicine, Queen\u2019s University, Kingston, ON, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Nesbitt","sequence":"additional","affiliation":[{"name":"Molecular Hemostasis Research Group, Department of Pathology and Molecular Medicine, Queen\u2019s University, Kingston, ON, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Rand","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatrics, Hospital for Sick Children and University of Toronto, Toronto, ON, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taneya","family":"Hossain","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatrics, Hospital for Sick Children and University of Toronto, Toronto, ON, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6913-2808","authenticated-orcid":false,"given":"Robert","family":"Klaassen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Ottawa, Ottawa, ON, Canada; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4649-9014","authenticated-orcid":false,"given":"Paula D.","family":"James","sequence":"additional","affiliation":[{"name":"Department of Medicine, Queen\u2019s University, Kingston, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5350-1763","authenticated-orcid":false,"given":"Manuel D.","family":"Carcao","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatrics, Hospital for Sick Children and University of Toronto, Toronto, ON, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lillicrap","sequence":"additional","affiliation":[{"name":"Molecular Hemostasis Research Group, Department of Pathology and Molecular Medicine, Queen\u2019s University, Kingston, ON, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"issue":"2","key":"2022050915223712100_B1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2012-01-405134","article-title":"Sequence and structure relationships within von Willebrand factor","volume":"120","author":"Zhou","year":"2012","journal-title":"Blood."},{"issue":"49","key":"2022050915223712100_B2","doi-asserted-by":"crossref","first-page":"35604","DOI":"10.1074\/jbc.M704047200","article-title":"Shear-induced disulfide bond formation regulates adhesion activity of von Willebrand factor","volume":"282","author":"Choi","year":"2007","journal-title":"J Biol Chem."},{"issue":"19","key":"2022050915223712100_B3","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood-2011-06-360297","article-title":"Lateral self-association of VWF involves the Cys2431-Cys2453 disulfide\/dithiol in the C2 domain","volume":"118","author":"Ganderton","year":"2011","journal-title":"Blood."},{"issue":"2","key":"2022050915223712100_B4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/jth.12466","article-title":"The von Willebrand factor predicted unpaired cysteines are essential for secretion","volume":"12","author":"Shapiro","year":"2014","journal-title":"J Thromb Haemost."},{"issue":"14","key":"2022050915223712100_B5","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1182\/blood-2018-10-876300","article-title":"The von Willebrand factor D\u2019D3 assembly and structural principles for factor VIII binding and concatemer biogenesis","volume":"133","author":"Dong","year":"2019","journal-title":"Blood."},{"issue":"28","key":"2022050915223712100_B6","doi-asserted-by":"crossref","first-page":"21238","DOI":"10.1016\/S0021-9258(19)36916-9","article-title":"The interaction of the von Willebrand factor-A1 domain with platelet glycoprotein Ib\/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein","volume":"268","author":"Cruz","year":"1993","journal-title":"J Biol Chem."},{"issue":"2","key":"2022050915223712100_B7","doi-asserted-by":"crossref","first-page":"EAAQ1477","DOI":"10.1126\/sciadv.aaq1477","article-title":"Autoregulation of von Willebrand factor function by a disulfide bond switch","volume":"4","author":"Butera","year":"2018","journal-title":"Sci Adv."},{"issue":"23","key":"2022050915223712100_B8","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1182\/blood-2009-12-257949","article-title":"The importance of vicinal cysteines, C1669 and C1670, for von Willebrand factor A2 domain function","volume":"115","author":"Luken","year":"2010","journal-title":"Blood."},{"issue":"1","key":"2022050915223712100_B9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood."},{"issue":"1","key":"2022050915223712100_B10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood."},{"author":"University of Sheffield","key":"2022050915223712100_B11"},{"issue":"7","key":"2022050915223712100_B12","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V88.7.2433.bloodjournal8872433","article-title":"Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor","volume":"88","author":"Eikenboom","year":"1996","journal-title":"Blood."},{"issue":"10","key":"2022050915223712100_B13","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/j.1538-7836.2005.01571.x","article-title":"Cysteine-mutations in von Willebrand factor associated with increased clearance","volume":"3","author":"Schooten","year":"2005","journal-title":"J Thromb Haemost."},{"issue":"2-3","key":"2022050915223712100_B14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000214853","article-title":"Laboratory diagnosis of von Willebrand disease type 1\/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide\/antigen ratio","volume":"121","author":"Gadisseur","year":"2009","journal-title":"Acta Haematol."},{"issue":"10","key":"2022050915223712100_B15","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood.V98.10.2973","article-title":"Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins","volume":"98","author":"Bod\u00f3","year":"2001","journal-title":"Blood."},{"issue":"9","key":"2022050915223712100_B16","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"Rodeghiero","year":"2010","journal-title":"J Thromb Haemost."},{"issue":"8","key":"2022050915223712100_B17","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1538-7836.2009.03499.x","article-title":"Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire","volume":"7","author":"Bowman","year":"2009","journal-title":"J Thromb Haemost."},{"issue":"2","key":"2022050915223712100_B18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/ijlh.12019","article-title":"Establishment and characterization of a new and stable collagen-binding assay for the assessment of von Willebrand factor activity","volume":"35","author":"Ni","year":"2013","journal-title":"Int J Lab Hematol."},{"issue":"6","key":"2022050915223712100_B19","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.thromres.2014.09.024","article-title":"Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays","volume":"134","author":"Favaloro","year":"2014","journal-title":"Thromb Res."},{"issue":"16","key":"2022050915223712100_B20","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2010-08-303727","article-title":"Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in\u00a0vitro and in\u00a0vivo mouse models","volume":"117","author":"Pruss","year":"2011","journal-title":"Blood."},{"issue":"23","key":"2022050915223712100_B21","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1182\/blood-2009-11-253120","article-title":"Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions","volume":"115","author":"Golder","year":"2010","journal-title":"Blood."},{"issue":"9","key":"2022050915223712100_B22","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1172\/JCI96400","article-title":"The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity","volume":"128","author":"Swystun","year":"2018","journal-title":"J Clin Invest."},{"issue":"23","key":"2022050915223712100_B23","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood.2018891192","article-title":"Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders","volume":"134","author":"Downes","year":"2019","journal-title":"Blood."},{"issue":"6","key":"2022050915223712100_B24","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1182\/blood-2005-02-0792","article-title":"Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis","volume":"106","author":"O\u2019Donnell","year":"2005","journal-title":"Blood."},{"issue":"7","key":"2022050915223712100_B25","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-11-122945","article-title":"A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor","volume":"111","author":"Gallinaro","year":"2008","journal-title":"Blood."},{"issue":"8","key":"2022050915223712100_B26","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood.V88.8.2951.bloodjournal8882951","article-title":"Quantitative analysis of von Willebrand factor propeptide release in\u00a0vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans","volume":"88","author":"Borchiellini","year":"1996","journal-title":"Blood."},{"issue":"5","key":"2022050915223712100_B27","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/jth.12875","article-title":"von Willebrand factor arginine 1205 substitution results in accelerated macrophage-dependent clearance in\u00a0vivo","volume":"13","author":"Rawley","year":"2015","journal-title":"J Thromb Haemost."},{"issue":"22","key":"2022050915223712100_B28","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1182\/blood-2009-09-244327","article-title":"The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF","volume":"115","author":"Haberichter","year":"2010","journal-title":"Blood."},{"issue":"3","key":"2022050915223712100_B29","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1182\/blood-2005-06-2330","article-title":"Correction of a murine model of von Willebrand disease by gene transfer","volume":"108","author":"Pergolizzi","year":"2006","journal-title":"Blood."},{"issue":"1","key":"2022050915223712100_B30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv."},{"issue":"19","key":"2022050915223712100_B31","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1182\/blood-2011-06-360875","article-title":"Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage","volume":"119","author":"Jacobi","year":"2012","journal-title":"Blood."},{"issue":"2","key":"2022050915223712100_B32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1182\/blood-2014-11-613935","article-title":"Variable content of von Willebrand factor mutant monomer drives the phenotypic variability in a family with von Willebrand disease","volume":"126","author":"Chen","year":"2015","journal-title":"Blood."},{"issue":"40","key":"2022050915223712100_B33","doi-asserted-by":"crossref","first-page":"15647","DOI":"10.1073\/pnas.0705175104","article-title":"Two Cys residues essential for von Willebrand factor multimer assembly in the Golgi","volume":"104","author":"Purvis","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"issue":"5","key":"2022050915223712100_B34","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/jth.13294","article-title":"Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms","volume":"14","author":"Alb\u00e1nez","year":"2016","journal-title":"J Thromb Haemost."},{"issue":"10","key":"2022050915223712100_B35","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood."},{"issue":"4","key":"2022050915223712100_B36","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/jth.12867","article-title":"No evidence for a direct effect of von Willebrand factor\u2019s ABH blood group antigens on von Willebrand factor clearance","volume":"13","author":"Groeneveld","year":"2015","journal-title":"J Thromb Haemost."},{"key":"2022050915223712100_B37","first-page":"1","article-title":"Clearance of mouse VWF propeptide is mediated by stabilin-2 and is regulated by N-linked glycan expression","volume":"2","author":"Rawley","year":"2018","journal-title":"Res Pract Thromb Haemost."},{"issue":"4","key":"2022050915223712100_B38","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood-2007-12-130740","article-title":"Basal secretion of von Willebrand factor from human endothelial cells","volume":"112","author":"Giblin","year":"2008","journal-title":"Blood."},{"issue":"4","key":"2022050915223712100_B39","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1365-2141.2003.04163.x","article-title":"Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII-binding capacity","volume":"120","author":"Hilbert","year":"2003","journal-title":"Br J Haematol."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/9\/2908\/1895935\/advancesadv2021005928.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/9\/2908\/1895935\/advancesadv2021005928.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T15:24:08Z","timestamp":1652109848000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/9\/2908\/483451\/Novel-cysteine-substitution-p-Cys1084Tyr-causes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,5,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005928","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"type":"print","value":"2473-9529"},{"type":"electronic","value":"2473-9537"}],"subject":[],"published":{"date-parts":[[2022,5,9]]}}}